Next Article in Journal
Green Synthesis, Characterization and Application of Natural Product Coated Magnetite Nanoparticles for Wastewater Treatment
Next Article in Special Issue
Therapeutic Applications of Biostable Silver Nanoparticles Synthesized Using Peel Extract of Benincasa hispida: Antibacterial and Anticancer Activities
Previous Article in Journal
pH-Responsive Nanoparticles for Cancer Immunotherapy: A Brief Review
Previous Article in Special Issue
The Potential of Silver Nanoparticles for Antiviral and Antibacterial Applications: A Mechanism of Action
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nanomaterials
Volume 10
Issue 8
10.3390/nano10081614
nanomaterials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cerium Oxide Nanoparticles and Their Efficient Antibacterial Application In Vitro against Gram-Positive and Gram-Negative Pathogens

by
Oana L. Pop
1,
Amalia Mesaros
2,*,
Dan C. Vodnar
1,
Ramona Suharoschi
1,
Flaviu Tăbăran
3,
Lidia Magerușan
4,
István Sz. Tódor
5,
Zoriţa Diaconeasa
1,
Adriana Balint
2,
Lelia Ciontea
2 and
Carmen Socaciu
1
1
Department of Food Science, University of Agricultural Science and Veterinary Medicine, 3-5 Calea Mănăştur Street, 400372 Cluj-Napoca, Romania
2
Physics and Chemistry Department, C4S Centre, Technical University of Cluj-Napoca, 28 Memorandumului Street, 400114 Cluj-Napoca, Romania
3
Department of Pathology, University of Agricultural Science and Veterinary Medicine, 3-5 Calea Mănăştur Street, 400372 Cluj-Napoca, Romania
4
National Institute for Research and Development of Isotopic and Molecular Technologies, 65-103 Donath Street, 400293 Cluj-Napoca, Romania
5
Faculty of Physics, Babeş-Bolyai University, 1st Kogălniceanu Street, 400084 Cluj-Napoca, Romania
*
Author to whom correspondence should be addressed.
Nanomaterials 2020, 10(8), 1614; https://doi.org/10.3390/nano10081614
Submission received: 25 June 2020 / Revised: 31 July 2020 / Accepted: 1 August 2020 / Published: 18 August 2020
(This article belongs to the Special Issue Antibacterial Activity of Nanoparticles)
Browse Figures
Versions Notes

Abstract

:
In this study, the antibacterial activity of cerium oxide nanoparticles on two Gram-negative and three Gram-positive foodborne pathogens was investigated. CeO2 nanoparticles (CeO2 nps) were synthesized by a Wet Chemical Synthesis route, using the precipitation method and the Simultaneous Addition of reactants (WCS–SimAdd). The as-obtained precursor powders were investigated by thermal analysis (TG–DTA), to study their decomposition process and to understand the CeO2 nps formation. The composition, structure, and morphology of the thermally treated sample were investigated by FTIR, Raman spectroscopy, X-ray diffraction, TEM, and DLS. The cubic structure and average particle size ranging between 5 and 15 nm were evidenced. Optical absorption measurements (UV–Vis) reveal that the band gap of CeO2 is 2.61 eV, which is smaller than the band gap of bulk ceria. The antioxidant effect of CeO2 nps was determined, and the antibacterial test was carried out both in liquid and on solid growth media against five pathogenic microorganisms, namely Escherichia coli, Salmonella typhimurium, Listeria monocytogenes, Staphylococcus aureus, and Bacillus cereus. Cerium oxide nanoparticles showed growth inhibition toward all five pathogens tested with notable results. This paper highlights the perspectives for the synthesis of CeO2 nps with controlled structural and morphological characteristics and enhanced antibacterial properties, using a versatile and low-cost chemical solution method.

1. Introduction

Antibiotics or antimicrobials have been widely utilized in various fields, such as medicine, food industry, agriculture, livestock, water treatment for diseases prevention, and pathogens eradication. Nevertheless, there is an increased concern related to multidrug-resistant microorganisms [1,2,3,4]. Worldwide, numerous scientists direct their efforts toward finding new alternatives for combating pathogens.
Among the many alternatives, such as plant extracts [5,6], antimicrobial peptides [7], and bee products [8,9], metal or metal oxide nanoparticles [10,11,12] are recently receiving increased attention. The properties found in the nanoparticle form of these materials can significantly differ from those of their bulk tantamount. Specific properties, such as considerably high contact surface and selectivity in the mediation of chemical transformations, facilitate their use in various areas.
Nanoparticles with various morphologies are utilized in multiple areas, including medicine, for the treatment or diagnosis [13,14,15,16,17,18] of pathogen-fighting systems [11,19] or improvement of the fuel quality [20,21].
Metal oxide nanoparticles, such as CeO2, have significant action on the antimicrobial activity and offer the plausibility of efficient pathogen removal from different environments. Furthermore, the stability and the slow release of metal ions from the nanoparticles are key features which make their usage advantageous. In comparison to other metal oxide nanoparticles, CeO2 has the quality of being an antioxidant due to the reversibility of its transfer from the reduced state into the oxidized state and resumes the process [22]. Its uses as an abrasive in semiconductor fabrication, or as a component in catalytic converters for auto machines exhaust systems, as a fuel additive to boost combustion, as an electrolyte for fuel, and as a UV-light absorber [21,23,24] are also well-known. Recently, nanoceria has been used as a colorimetric indicator for antioxidants activity due to the color changes induced by the modifications of cerium oxidation states at nanoparticle surface [25,26,27]. It was established that CeO2 nanoparticles have the capacity to initiate their mechanism by the modulation of the oxygen environment [28]. The properties of these CeO2 nanoparticles prove important possible biomedical applications. Scattered literature regarding the antibacterial activity of CeO2 nanoparticles is available. The effect against E. coli and B. subtilis [11], a comparison of the anti-bactericidal activity of bulk and nano CeO2 against the same Gram-negative bacteria [29,30], and cytotoxicity on nitrogen-fixing bacteria [31] are reported. Many studies have reported the synthesis of ceria nanoparticles (nps), using different cerium salts (acetate or nitrate) and different reactants (citric acid, ammonia, or hydrogen peroxide), and organic solvents/stabilizers (oleic acid, oleylamine, or diphenyl ether) to prevent particle agglomeration [32,33,34]. The addition of these organic species to the aqueous solution directly affects the stabilization level, the nucleation, and the growth processes of the CeO2 nps in the homogeneous solutions.
The aim of our work was the investigation of antibacterial properties of CeO2 nanoparticles against a wider range of pathogens, namely Escherichia coli, Salmonella typhimurium, Listeria monocytogenes, Staphylococcus aureus, and Bacillus cereus. A simple, reproducible, controllable, and low-cost wet-chemical synthesis method was used for the preparation of CeO2 nps. This precipitation-type method consists of the simultaneous addition of reactants (SimAdd) in the presence of an anti-agglomeration agent, under pH control, with the formation of cerium oxalate type salt as a precursor [35,36,37]. Based on the precursor characterization—thermal analysis and FTIR—the particle dimensionality and aggregation can be controlled. The CeO2 nps were characterized by using spectroscopic and microscopic methods, and their antioxidant and antibacterial activity was tested on two Gram-negative and three Gram-positive pathogens, respectively.

2. Materials and Methods

2.1. Materials

The chemicals used in the synthesis of the CeO2 nanoparticles are cerium nitrate hexahydrate, Ce(NO3)3∙6H2O (Sigma Aldrich, Chemie GmbH, Taufkirchen, Germany)—cation source, oxalic acid dihydrate, and H2C2O4∙2H2O (Alfa Aesar, Thermo Fisher Scientific Chemicals, Inc. Ward Hill, MA, USA)—precipitation agent, ammonia solution NH4OH, 30%NH3 (Alfa Aesar, Thermo Fisher Scientific Chemicals, Inc. Ward Hill, MA, USA) for pH control, tetraethylammonium hydroxide, (C2H5)4N(OH) as an anti-agglomeration agent, and NH4Cl (Alfa Aesar, Thermo Fisher Scientific Chemicals, Inc. Ward Hill, MA, USA) as flux. All chemicals were reagent grade and used without further purification.

2.2. Synthesis of Cerium Oxide Nanoparticles

The CeO2 nps samples were prepared via the Wet-Chemical Synthesis route, which consists of the Simultaneous Addition of reagents technique (WCS–SimAdd), using cerium nitrate and oxalic acid 50 mM aqueous solutions. The chemical reaction is presented in the Supplementary Materials file. The precipitation was carried out under continuous magnetic stirring, and the pH value was adjusted to 7 ± 0.2 by adding the ammonium hydroxide. Moreover, a small amount (1 vol%) of tetraethylammonium hydroxide solution was added to prevent the agglomeration of the particles. The post-precipitation stage consisted of 24 h aging, separation by filtering, and drying. The precursor nano-powders were intimately mixed with NH4Cl (flux), and the thermal treatment was performed at 400 °C/1 h, in air, at a heating rate of 300 °C/h. The thermally treated powders were washed several times with distilled water, until the filtrate was Cl− free. Finally, the nano-powders were separated by centrifugation and dried in the oven at 110 °C for 1 h. A yellow aqueous solution (2 mM) was obtained by dispersing a specific mass of ceria nps in distilled water.

2.3. Characterization of Cerium Oxide Nanoparticles

The thermal decomposition process of cerium oxalate–type precursor was monitored by thermal analysis, using a Mettler Toledo TGA/SDTA851 (Greifensee, Switzerland) system, a platinum crucible, and a heating rate of 10 K/min, in a static air atmosphere up to 500 °C. The chemical nature of the precursor and final oxide was analyzed by Fourier Transform Infrared Spectroscopy (FTIR), using a Tensor 27 Bruker FTIR spectrophotometer (Bruker Optik GmbH, Germany). The crystalline structure of the CeO2 nano-powders was determined by X-ray diffraction (XRD) investigations, which were performed at room temperature, by means of a Bruker AXS D8 Discover diffractometer (Bruker, Karlsruhe, Germany) operating at 40 kV, 40 mA, CuKα radiation λ = 1.54056 Å. The hydrodynamic diameter was determined by dynamic light scattering (DLS) measurements, using a Brookhaven Instruments Corporation (Holtsville, NY, USA), a goniometer, and a laser light-scattering system. The acquisition time was set to 90 s, a laser radiation wavelength of 632.8 nm was used, and the angle at which data acquisition was performed was 90°. During long-term storage, the solution gradually lost its stability due to the formation of nanoparticle aggregates. TEM was utilized to characterize the morphology of CeO2 nps. A JEOL JEM1010 transmission electron microscope (JEOL USA, Inc., Peabody, MA, USA) was used, operating at an accelerating voltage of 100 kV and equipped with a MegaViewIII CCD camera. The optical characterization was performed by a Jasco V 530 spectrophotometer (Jasco Corporation, Tokyo, Japan), in the range of 200–800 nm. The Raman spectra of the CeO2 nanoparticles were recorded at room temperature, using a Renishaw in Via Reflex Raman Microscope (New Mills, UK) equipped with a RenCam CCD detector. The Raman system was operated with 532 nm laser line, and the spectra were recorded by adding 4 accumulations, each with a 40 s exposure time, acquired by using 13.5 mW laser power with a 4 cm−1 resolution.

2.4. Antioxidant Properties of CeO2 Nps SCAVENGING Effect on ABTS Radicals

The scavenging properties of CeO2 nps against radical cations ABTS+ (2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) were determined according to the procedure described in other studies [38,39], adapted to a microplate of 96 wells. The ABTS assay is based on the capacity of a sample to scavenge the ABTS radical cation (ABTS. ABTS +), as compared to a standard antioxidant (Trolox). The blue–green ABTS+ solution was produced by the reaction between a 7 mM aqueous solution of ABTS and a 2.45 mM potassium persulfate, in a dark medium, and at room temperature, for 12–16 h before use. ABTS+ working solution was obtained by diluting the stock solution with ethanol, resulting in an absorbance of 0.70 ± 0.02 AU at 734 nm. Then, 20 µL of Trolox or CeO2 nps solution at different concentrations were added to 170 µL ABTS+ solutions, and the absorbance was measured after 6 min of incubation, in the dark, and at room temperature, using a microplate reader. The results were expressed as µmol Trolox per Gram sample.

2.5. Antibacterial Activity

The antibacterial activity of the tested nanoparticles was evaluated by using different methods, such as disk diffusion tests, UV–Vis measurements of the optical density (OD), the number of colony-forming units (CFUs) on solid medium, the resazurin test, and bacterial viability, using confocal microscopy. The five pathogenic strains used in the study were Escherichia coli ATC 25922 (Microbiologics), Salmonella typhimurium ATCC 14028 (Microbiologics) Listeria monocytogenes ATCC 35152 (Liofilclem), Staphylococcus aureus ATCC 65389 (MediTech), and Bacillus cereus ATCC 11778 (MediTech).
Disk diffusion method—About 15 mL of sterile nutrient agar (Bioaqua, Targu-Mures) was poured into the sterile Petri dish. Triplicate plates were inoculated with 200 µL of the overnight culture (approximately 108 CFU/mL) of the targeted pathogenic bacteria, which were spread on the plate, using sterile Drigalski spatulas. On the solid medium were gently placed up to 6 paper disks that were soaked with a fixed concentration of CeO2 nps solution. The plates were incubated for 24 h at 37 ± 1 °C, prior to the determination of results. The zone of inhibition around each of the paper disks was measured and expressed as millimeters in diameter. Gentamicin was used as the control.
Minimum Inhibitory Concentration (MIC)—Broth dilution tests were conducted in standard trays containing 96 wells, to evaluate the MIC of the cerium oxide nanoparticles. To obtain sequential dilutions, 150 µL of the cerium oxide nanoparticles was homogenized with 150 µL of nutrient broth; afterward, the solution was well mixed, and then 150 µL of the mixture was transferred in the next well containing 150 µL of nutrient broth. The final volume was of 200 µL in each well after the addition of 50 µL of 24-hour-old bacteria inoculum. The final solution was allowed to grow at 37 °C for 24 h. Growth curves for the control of pathogenic cells incubated with three different concentrations of CeO2 nps were measured at OD550. The MIC value was the lowest concentration of the nanoparticles that did not permit any visible growth of the pathogenic bacteria during 24 h of incubation because of turbidity. The negative control was the sample where no bacteria were added, and the positive control was the sample where no cerium oxide nanoparticles were added. The turbidity was measured by using UV–Vis spectroscopy (microplate reader (HT BioTek Synergy) at 550 nm. The same experiment was conducted, using gentamicin as an antibiotic. All the experiments were performed in triplicates and were repeated twice.
Minimum Bactericidal Concentration (MBC)—To prevent the possibility of misinterpretation due to the turbidity of insoluble compounds, the MBC was established by sub-culturing the above (MIC) serial dilutions after the incubation time in nutrient agar plates, using a 0.01 mL loop, and further incubating the dilutions at 37 °C for 24 h. The MBC was considered to be the lowest concentration that prevents the growth of the bacterial colony on this solid medium.
Bacterial viability using confocal microscopy—The confocal laser scanning microscope - Zeiss LSM 710 (Oberkochen, Germany) - is a method that allowed us to view live and dead bacteria. Bacteria cells culture (~108 CFU) were treated with 50 µg/mL of CeO2 nps for 24 h. A control with no treatment was made for each pathogen. Prior to the confocal microscopy assay, the bacteria cells were mixed, for coloration, with a LIVE/DEAD® BacLight™ bacterial viability Kit, L-7007, for 15 min, in the dark. Aliquots of 50 µL of the colored bacteria were placed on a microscope slide, fixed using a flame, rinsed, and dried.
Time kill assay—The potential CeO2 nanoparticle was subject to the time killing assay. An inoculum of the tested pathogens (10 µL), at a concentration of 108 CFU/mL, was mixed with 100 µL of solution containing growth medium and nanoparticles, to a final concentration of 50 µg/mL. The negative controls were the samples in which no nanoparticles were utilized. The growth of bacterial species was assessed at every 1 h interval, by measuring the optical density at 550 nm with the microplate reader.

3. Results and Discussion

It is well-known that the critical step in the synthesis of metal oxide by wet-chemical methods is the thermal decomposition of the obtained precursor. The thermal analysis method (DTA–TG) allowed us to investigate the chemical transformation of the oxalate-type precursor into oxide powders during heating (see Figure 1a). The thermal behavior of the synthetized precursor through simultaneous DTA–TG measurements reveals two weight-loss processes. In the low temperature range, the DTA curve illustrates an endothermic process with the maximum temperature centered around 150 °C, accompanied by a mass loss of 23.8% on the TG curve. This first decomposition step is attributed to the dehydration of the precursor with the loss of around 10 water molecules and the formation of anhydrous cerium oxalate [40,41,42]. The second weight loss (~28.5%) is observed at temperatures ranging between 250 and 350 °C and corresponds to the oxidative decomposition of the oxalate group, as indicated by the exothermic effect, whose maxima is located at 298 °C. Almost no weight loss is observed at temperatures higher than 350 °C in the TG curve, indicating that the oxalate precursor was completely decomposed with the formation of CeO2. This decomposition behavior confirms that the chemical composition of the oxalate precursor is close to the molecular formula of Ce2(C2O4)3∙10H2O, which is in concordance with the literature data [40,41,43]. Based on these observations, one can assume that the precursor decomposition takes place according to the following chemical reactions:
100–200 °C: Ce2(C2O4)3·10H2O → Ce2(C2O4)3 + 10H2O
250–350 °C: Ce2(C2O4)3 → 2CeO2 + 2CO2 + 4CO
To identify the crystalline phases and to estimate the average particle sizes, an XRD investigation was performed. The XRD pattern of the oxide powders obtained after annealing at 400 °C for 1 h is presented in Figure 1b. All the reflections were indexed with those of the pure cubic fluorite structure of CeO2 (JCDD PDF 034-0394) [30,33,40]. The average crystallite sizes of the sample were calculated by using the Debye–Scherrer formula:
D p = 0.9 ⋅ λ β ⋅ c o s θ
where Dp is the average crystallite size, λ is the wavelength of the CuKα line, θ is the Bragg angle, and β is the Full Width at Half-Maximum (FWHM) of the diffraction peak in radians. The average crystallite size calculated for (111), (200), (220), and (311) reflections was about 7 nm.
To further analyze the morphology—size and shape—of CeO2 nps, TEM–HRTEM and DLS characterizations were carried out, and the results are presented in Figure 2a–c. The TEM images illustrate the presence of aggregates with pseudo-spherical shapes. This behavior to form larger and denser nanoparticle aggregates during the thermal treatment is characteristic for oxalate-type precursors [42]. DLS measurements of the CeO2 nps suspensions present an average hydrodynamic diameter (Dh) of 9.65 nm, with the size of the nanoparticles averaging in the range of 5–20 nm. This larger value for Dh is related to the interference of the dispersant into the hydrodynamic diameter.
Figure 3a shows the FTIR spectra of the synthetized CeO2 nps and the cerium oxalate–type precursor. The large band observed in the 3500–3000 cm−1 domain can be assigned to the collective in-phase symmetric ν(O–H) stretching vibration [44]. The asymmetric νasym(COO−) observed at 1598 cm−1 and the symmetric νsym(COO−) stretching modes observed 1356 and 1308 cm−1 are assigned to the oxalate modes [45]. The difference in their frequencies, Δν(COO−) = νasym(COO−)—νsym(COO−), is around 298 cm−1 and is indicative of the formation of a bidentate coordination bond between the cerium ions and the oxalate group. Moreover, the low-intensity vibration bands at 1460 and 1418 cm−1 suggest the existence of both mononuclear and binuclear bidentate oxalate complexes [45,46]. The low intensity band observed at 1095 cm−1 is characteristic for νas(C–O–C) and ν(Ce–O–C) vibration [45,47]. The bands at 795, 485, and 365 cm−1 are attributed to the δ(O–C=O) bridging oxalate group and to the interaction of the metal–oxygen vibration ν(Ce–O) [45,46,47,48]. The FTIR spectrum of CeO2 nps confirms the total conversion of the oxalate precursor into ceria by thermal treatment. The presence of the absorption bands characteristic to Ce–O vibrations sustains the main phase of the as-prepared particles as cerium oxide, and the thermal treatment assures the complete decomposition of the oxalate-type precursor.
Raman spectroscopy is one of the major tools utilized in the study of crystallinity, purity, and any defect levels connected to the nanomaterials. A typical Raman spectrum for bulk CeO2 with cubic fluorite structure presents a single strong peak at 464 cm−1, assigned to the F2g symmetry modes of CeO2 [49,50]. The Raman spectrum of the synthetized CeO2 nps (see Figure 3b) exhibits a strong Raman absorption peak at 461 cm−1 and two weak absorption peaks at 610 and 740 cm−1. The Raman peak at 461 cm−1 corresponds to the triply degenerate F2g mode of symmetric stretching vibration of oxygen ions around Ce4+ cations and therefore confirms the cubic fluorite structure. The slight broadness of the peak is attributed to the reduction of the particle size to nanometric ranges. The shift in the peak position toward the lower energy value and the broad peaks at 610 and 740 cm−1 are due to the presence of point defects generated by oxygen vacancies [49,50,51].
The UV–Vis spectrum is shown in Figure 4. The maximum absorption peak at 350 nm is assigned to the charge transfer between the O 2p and Ce 4f states in O2− and Ce4+. Compared with CeO2 bulk, where the absorption peak is around 389 nm, the maximum intensity for the synthetized CeO2 nps is shifted toward a lower wavelength value (blueshift) [50]. Based on the absorption spectra, the direct band gap of CeO2 nps was determined from the following relationship:
αhν = A (hν − Eg)n/2
where α is the optical absorption coefficient, α = A/d’; A—is the measured absorbance, and d’ is the thickness of sample in a UV–Vis cell (0.4 cm); hν is the photon energy; and Eg is the direct band gap of the sample. The extrapolation of the linear part of the domain of (αhν)2 vs. hν to the αhν = 0 (where hν = Eg) allows the determination of the direct band gap of Eg value (2.61 eV). The red shift in the band gap is associated with oxygen vacancies and existence of Ce3+ to the nanoparticle surface. Oxygen defects and Ce3+ ions generate intermediate defect energy states in the CeO2 band gap. Due to the presence of these states, the direct transition of electrons from O 2p to Ce 4f is slowed down, resulting in the decrease of band gap value [50,52,53].
To evaluate the antioxidant potential of CeO2 nps, the ABTS (2,2’-azino-bis(3-ethylbenzthiazoline)-6-sulphonic acid) assay was tested. The ABTS method is indicated for a suitable and continuous spectrophotometric measurement of any potential radical formations. ABTS creates a characteristic cation radical (ABTS+) that can be easily followed and can allow the measurement of the initial rate of radical formation. The obtained results (see Figure 5 and Table S1 in Supplementary Materials file) have clearly demonstrated that the CeO2 nps is a radical scavenger and can inhibit the ABTS+ radical formation in a dose-dependent manner [54]. The results were expressed as Trolox equivalents. Trolox is a water-soluble analogue of vitamin E. Trolox is an antioxidant that has been shown to prevent lipid peroxidation in vivo. Previous publications have shown that vitamin E is effective in preventing oxidative harm from iron and other redox-active metals in vivo and in vitro, likely by reacting with hydroxyl radicals or downstream radical intermediates [55,56]. It can be easily concluded that the antioxidant activity increases in direct proportionality with the nanoparticle concentration.
Compared with bulk, CeO2 nps exhibit superior properties due to their small size, which allows a rapid adsorption of pathogens. Many studies have shown that the CeO2 nps exhibit excellent antibacterial activity against Gram-positive and Gram-negative bacteria due to the generation of reactive oxygen species (ROS) [57,58,59]. In healthy cells, CeO2 nps act as antioxidants by scavenging ROS at a physiological pH, while, in pathogens—under low-pH environment—CeO2 nps act as a pro-oxidant by generating ROS and producing cell damage. Zhang et al. [59] presented a systematic research on the antibacterial mechanism and further summarized the main steps and influencing factors of these reactions.
The antibacterial activity of CeO2 nps was evaluated by using the microdilution method, and the corresponding MIC and MBC values were evaluated against two Gram-negative and three Gram-positive pathogens. The correspondent values are given in Table 1 and Table 2, respectively. The cerium oxide nanoparticles demonstrated antibacterial properties against all the tested pathogens in relative low concentrations.
The antibacterial activity of CeO2 nps discloses that the same concentration of nanoparticles against Escherichia coli and Salmonella typhimurium resulted in different diameters of inhibition, with these being 9 and 10 mm, respectively. Regarding the Gram-positive pathogens, the highest inhibition was registered in the case of Listeria monocytogenes, followed by Bacillus cereus and Staphylococcus aureus. The MBC results reveal that the highest sensitivity of solely 1.07 g/L CeO2 nps can be observed in Salmonella typhimurium and Listeria monocytogenes. The difference in the action of CeO2 nps against the Gram-positive and Gram-negative pathogens is primarily related to the different structure and compactness of their cell walls. Usually, Gram-positive bacteria have a thicker, waxy cell wall, making them more resistant to the antimicrobial activity of CeO2 nps in comparison with Gram-negative bacteria [60,61]. For example, the Gram-positive Bacillus cereus has a cell wall of 55.4 nm, while the Gram-negative S. typhimurium has a cell wall of only 2.4 nm [62]. Even if important functional differences can be seen between the Gram-positive and Gram-negative bacteria cell wall, in the DNA-based molecular taxonomy, some pathogens have a similar response to the same antibacterial agents [63].
The antibacterial effect of CeO2 nps is confirmed by the confocal microscopy images from Figure 6. The results clearly evidence that the inhibitory effect of CeO2 nps is present at a lower concentration, with respect to gentamicin (the standard drug). This fact guarantees the presence of the antibacterial action of CeO2 nps against the tested pathogens.
The time kill assay shows an inhibitory effect in a time-dependent manner, in Figure 7, indicating that CeO2 nps interaction with the tested pathogens results in cell damage. It can be observed that the bacterial growth was inhibited from the first hour.
A feasible mechanism of action can be explained by the fact that the CeO2 nps are carrying positive charges, and the bacteria are charged negatively, inducing electromagnetic attraction. This attraction ensures direct contact between nanoparticles and bacteria, leading to oxidation and bacterial cellular death [11].

4. Conclusions

Cerium oxide nanoparticles have been designed through a wet chemical method by using the simultaneous addition of reactants (WCS–SimAdd). A better understanding of the decomposition mechanism for as-obtained oxalate precipitate was achieved by DTA–TG and FTIR analyses. The cubic fluorite structure of the cerium oxide nps was ascertained by XRD and Raman spectroscopy. TEM and DLS revealed the morphology, showing that the sizes are in the range of 5–20 nm, with pseudo-spherical shapes and a lower tendency to form aggregates. The oxygen vacancies and formation of Ce3+ evidenced by Raman and UV–Vis spectroscopies are correlated to the particle low-dimensionality.
Experiments prove that the synthetized CeO2 nps exhibit excellent antibacterial activity against the five tested bacterial species: E. coli, S. typhimurium, L. monocytogenes, S. aureus, and B. cereus. Low MIC values were registered, a result that suggests the suitable antibacterial characteristics of CeO2 nps. Antibacterial action is attributable to the direct interaction between the cerium oxide nanoparticles and the bacteria which induces the cellular death of these pathogens. In overview, this study evidenced the potential antibacterial property of cerium oxide nanoparticles, a fact that leads to new approaches in the development of biomedical and food applications. Further studies, such as long-term treatment, are important for a better understanding and the application of CeO2 nps in various antibacterial applications.

Supplementary Materials

The following are available online at https://www.mdpi.com/2079-4991/10/8/1614/s1, Table S1: The antioxidant activity data.

Author Contributions

Formal analysis, A.B.; investigation, R.S., F.T., L.M., I.S.T. and Z.D.; methodology, A.M. and D.C.V.; project administration, O.L.P. and A.M.; supervision, A.M., L.C. and C.S.; writing—original draft, O.L.P.; writing—review and editing, A.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the frame of European Social Fund, Human Resources Development Operational ProGramme 2007–2013, project no. POSDRU/159/1.5/S/132765, and Partnership in Priority Areas ProGramme-PNII, developed with the support of MEN-UEFISCDI Project No. 154 (PN-II-PT-PCCA-2013-4-0743).

Acknowledgments

The publication was supported by funds from the National Research Development Projects to finance excellence (PFE)-37/2018–2020, granted by the Romanian Ministry of Research and Innovation.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Allen, H.K.; Levine, U.Y.; Looft, T.; Bandrick, M.; Casey, T.A. Treatment, promotion, commotion: Antibiotic alternatives in food-producing animals. Trends Microbiol. 2013, 21, 114–119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Defoirdt, T.; Sorgeloos, P.; Bossier, P. Alternatives to antibiotics for the control of bacterial disease in aquaculture. Curr. Opin. Microbiol. 2011, 14, 251–258. [Google Scholar] [CrossRef] [PubMed]
  3. Nigam, A.; Gupta, D.; Sharma, A. Treatment of infectious disease: Beyond antibiotics. Microbiol. Res. 2014, 169, 643–651. [Google Scholar] [CrossRef] [PubMed]
  4. Wilson, H.L.; Buchanan, R.M.; Allan, B.; Tikoo, S.K. Milk-derived antimicrobial peptides to protect against neonatal diarrheal disease: An alternative to antibiotics. Procedia Vaccinol. 2012, 6, 21–32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Diaconeasa, Z.; Ranga, F.; Rugina, D.; Leopold, L.; Pop, O.L.; Vodnar, D.C.; Lucian, C.; Carmen, S. Phenolic content and their antioxidant activity in various berries cultivated in Romania. Bull. UASVM Food Sci. Technol. 2015, 72, 1. [Google Scholar] [CrossRef]
  6. Gyawali, R.; Hayek, S.A.; Ibrahim, S.A. Plant extracts as antimicrobials in food products: Mechanisms of action, extraction methods, and applications. In Handbook of Natural Antimicrobials for Food Safety and Quality; Taylor, T.M., Ed.; Woodhead Publishing: Sawston, UK, 2014. [Google Scholar]
  7. De Freitas Lima, S.M.; de Pádua, G.M.; da Costa Sousa, M.G.; de Souza Freire, M.; Franco, O.L.; Rezende, T.M.B. Antimicrobial peptide-based treatment for endodontic infections—Biotechnological innovation in endodontics. Biotechnol. Adv. 2015, 33, 203–213. [Google Scholar] [CrossRef]
  8. Mihai, C.M.; Mărghitaş, L.A.; Dezmirean, D.S.; Chirilă, F.; Moritz, R.F.; Schlüns, H. Interactions among flavonoids of propolis affect antibacterial activity against the honeybee pathogen Paenibacillus larvae. J. Invertebr. Pathol. 2012, 110, 68–72. [Google Scholar] [CrossRef]
  9. Urcan, A.; Criste, A.; Dezmirean, D.; Bobiș, O.; Marghitas, L.; Margaoan, R.; Hrinca, A. Antimicrobial Activity of Bee Bread Extracts Against Different Bacterial Strains. Bull. Univ. Agric. Sci. Vet. Med. Cluj-Napoca. Anim. Sci. Biotechnol. 2018, 75, 85–91. [Google Scholar] [CrossRef] [Green Version]
  10. Dizaj, S.M.; Lotfipour, F.; Barzegar-Jalali, M.; Zarrintan, M.H.; Adibkia, K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater. Sci. Eng. C 2014, 44, 278–284. [Google Scholar] [CrossRef]
  11. Pelletier, D.A.; Suresh, A.K.; Holton, G.A.; McKeown, C.K.; Wang, W.; Gu, B.; Mortensen, N.P.; Allison, D.P.; Joy, D.C.; Allison, M.R. Effects of engineered cerium oxide nanoparticles on bacterial growth and viability. Appl. Environ. Microbiol. 2010, 76, 7981–7989. [Google Scholar] [CrossRef] [Green Version]
  12. Dahle, J.T.; Arai, Y. Environmental geochemistry of cerium: Applications and toxicology of cerium oxide nanoparticles. Int. J. Environ. Res. Public Health 2015, 12, 1253–1278. [Google Scholar] [CrossRef] [PubMed]
  13. Bridle, H. Nanotechnology for Detection of Waterborne Pathogens. In Waterborne Pathogens; Elsevier: Amsterdam, The Netherlands, 2014; pp. 291–318. [Google Scholar]
  14. Chigurupati, S.; Mughal, M.R.; Okun, E.; Das, S.; Kumar, A.; McCaffery, M.; Seal, S.; Mattson, M.P. Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing. Biomaterials 2013, 34, 2194–2201. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Choi, H.; Lee, K.; Hur, N.; Lim, H. Cerium oxide-deposited mesoporous silica nanoparticles for the determination of carcinoembryonic antigen in serum using inductively coupled plasma-mass spectrometry. Anal. Chim. Acta 2014, 847, 10–15. [Google Scholar] [CrossRef] [PubMed]
  16. Coman, C.; Leopold, L.F.; Rugină, O.D.; Barbu-Tudoran, L.; Leopold, N.; Tofană, M.; Socaciu, C. Green synthesis of gold nanoparticles by Allium sativum extract and their assessment as SERS substrate. J. Nanoparticle Res. 2014, 16, 2158. [Google Scholar] [CrossRef]
  17. Wason, M.S.; Colon, J.; Das, S.; Seal, S.; Turkson, J.; Zhao, J.; Baker, C.H. Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomed. Nanotechnol. Biol. Med. 2013, 9, 558–569. [Google Scholar] [CrossRef] [Green Version]
  18. Hosseini, M.; Mozafari, M. Cerium oxide nanoparticles: Recent advances in tissue engineering. Materials 2020, 13, 3072. [Google Scholar] [CrossRef]
  19. Azam, A.; Ahmed, A.S.; Oves, M.; Khan, M.S.; Habib, S.S.; Memic, A. Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: A comparative study. Int. J. Nanomed. 2012, 7, 6003. [Google Scholar] [CrossRef] [Green Version]
  20. Mori, T.; Ou, D.R.; Zou, J.; Drennan, J. Present status and future prospect of design of Pt–cerium oxide electrodes for fuel cell applications. Prog. Nat. Sci. Mater. Int. 2012, 22, 561–571. [Google Scholar] [CrossRef] [Green Version]
  21. Selvan, V.A.M.; Anand, R.; Udayakumar, M. Effect of Cerium Oxide Nanoparticles and Carbon Nanotubes as fuel-borne additives in Diesterol blends on the performance, combustion and emission characteristics of a variable compression ratio engine. Fuel 2014, 130, 160–167. [Google Scholar] [CrossRef]
  22. Corral-Diaz, B.; Peralta-Videa, J.R.; Alvarez-Parrilla, E.; Rodrigo-García, J.; Morales, M.I.; Osuna-Avila, P.; Niu, G.; Hernandez-Viezcas, J.A.; Gardea-Torresdey, J.L. Cerium oxide nanoparticles alter the antioxidant capacity but do not impact tuber ionome in Raphanus sativus (L). Plant Physiol. Biochem. 2014, 84, 277–285. [Google Scholar] [CrossRef]
  23. Mos, R.; Petrisor, T., Jr.; Nasui, M.; Calleja, A.; Puig, T.; Ciontea, L.; Petrisor, T. Enhanced structural and morphological properties of Gd-doped CeO2 thin films obtained by polymer-assisted deposition. Mater. Lett. 2014, 124, 306–309. [Google Scholar] [CrossRef]
  24. Snow, S.J.; McGee, J.; Miller, D.B.; Bass, V.; Schladweiler, M.C.; Thomas, R.F.; Krantz, T.; King, C.; Ledbetter, A.D.; Richards, J. Inhaled diesel emissions generated with cerium oxide nanoparticle fuel additive induce adverse pulmonary and systemic effects. Toxicol. Sci. 2014, 142, 403–417. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Andrei, V.; Sharpe, E.; Vasilescu, A.; Andreescu, S. A single use electrochemical sensor based on biomimetic nanoceria for the detection of wine antioxidants. Talanta 2016, 156, 112–118. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Karimi, A.; Othman, A.; Andreescu, S. Portable enzyme-paper biosensors based on redox-active CeO2 nanoparticles. In Methods in Enzymology; Elsevier: Amsterdam, The Netherlands, 2016; pp. 177–195. [Google Scholar]
  27. Othman, A.; Norton, L.; Finny, A.S.; Andreescu, S. Easy-to-use and inexpensive sensors for assessing the quality and traceability of cosmetic antioxidants. Talanta 2020, 208, 120473. [Google Scholar] [CrossRef] [PubMed]
  28. Das, S.; Singh, S.; Dowding, J.M.; Oommen, S.; Kumar, A.; Sayle, T.X.; Saraf, S.; Patra, C.R.; Vlahakis, N.E.; Sayle, D.C. The induction of angiogenesis by cerium oxide nanoparticles through the modulation of oxygen in intracellular environments. Biomaterials 2012, 33, 7746–7755. [Google Scholar] [CrossRef] [Green Version]
  29. Kuang, Y.; He, X.; Zhang, Z.; Li, Y.; Zhang, H.; Ma, Y.; Wu, Z.; Chai, Z. Comparison study on the antibacterial activity of nano-or bulk-cerium oxide. J. Nanosci. Nanotechnol. 2011, 11, 4103–4108. [Google Scholar] [CrossRef]
  30. Krishnan, A.; Sreeremya, T.S.; Murray, E.; Ghosh, S. One-pot synthesis of ultra-small cerium oxide nanodots exhibiting multi-colored fluorescence. J. Colloid Interface Sci. 2013, 389, 16–22. [Google Scholar] [CrossRef]
  31. Bandyopadhyay, S.; Peralta-Videa, J.R.; Plascencia-Villa, G.; José-Yacamán, M.; Gardea-Torresdey, J.L. Comparative toxicity assessment of CeO2 and ZnO nanoparticles towards Sinorhizobium meliloti, a symbiotic alfalfa associated bacterium: Use of advanced microscopic and spectroscopic techniques. J. Hazard. Mater. 2012, 241, 379–386. [Google Scholar] [CrossRef]
  32. Babenko, L.; Zholobak, N.; Shcherbakov, A.; Voychuk, S.; Lazarenko, L.; Spivak, M.Y. Antibacterial activity of cerium colloids against opportunistic microorganisms in vitro. Microbiol. J. 2012, 74, 54–62. [Google Scholar]
  33. Chen, H.-I.; Chang, H.-Y. Synthesis of nanocrystalline cerium oxide particles by the precipitation method. Ceram. Int. 2005, 31, 795–802. [Google Scholar] [CrossRef]
  34. Ivanova, O.S.; Shekunova, T.O.; Ivanov, V.K.; Shcherbakov, A.B.; Popov, A.L.; Davydova, G.A.; Selezneva, I.I.; Kopitsa, G.P.; Tret’yakov, Y.D. One-stage synthesis of ceria colloid solutions for biomedical use. Dokl. Chem. 2011, 437, 103–106. [Google Scholar] [CrossRef]
  35. Mesaros, A.; Ghitulica, C.D.; Popa, M.; Mereu, R.; Popa, A.; Petrisor, T., Jr.; Gabor, M.; Cadis, A.I.; Vasile, B.S. Synthesis, structural and morphological characteristics, magnetic and optical properties of Co doped ZnO nanoparticles. Ceram. Int. 2014, 40, 2835–2846. [Google Scholar] [CrossRef]
  36. Muresan, L.; Popovici, E.; Indrea, E. Structural and luminescence characterization of yttrium oxide based phosphors prepared by wet-chemical method. J. Optoelectron. Adv. Mater. 2011, 13, 183. [Google Scholar]
  37. Marius, M.; Popovici, E.J.; Barbu-Tudoran, L.; Indrea, E.; Mesaros, A. Cerium-doped yttrium aluminate-based phosphors prepared by wet-chemical synthesis route: Modulation of the luminescence color by changing the host-lattice composition. Ceram. Int. 2014, 40, 6233–6239. [Google Scholar] [CrossRef]
  38. Arnao, M.B.; Cano, A.; Acosta, M. The hydrophilic and lipophilic contribution to total antioxidant activity. Food Chem. 2001, 73, 239–244. [Google Scholar] [CrossRef]
  39. Zhao, L.; Peralta-Videa, J.R.; Peng, B.; Bandyopadhyay, S.; Corral-Diaz, B.; Osuna-Avila, P.; Montes, M.O.; Keller, A.A.; Niu, G.; Gardea-Torresdey, J.L. Alginate modifies the physiological impact of CeO2 nanoparticles in corn seedlings cultivated in soil. J. Environ. Sci. 2014, 26, 382–389. [Google Scholar] [CrossRef] [Green Version]
  40. Gabal, M.; Elroby, S.A.; Obaid, A. Synthesis and characterization of nano-sized ceria powder via oxalate decomposition route. Powder Technol. 2012, 229, 112–118. [Google Scholar] [CrossRef]
  41. Maslennikov, D.; Matvienko, A.; Chizhik, S.; Sidelnikov, A. Synthesis and structural characterization of ceria nanoparticle agglomerates with shape inherited from an oxalate precursor. Ceram. Int. 2019, 45, 4137–4141. [Google Scholar] [CrossRef]
  42. Zhao, P.; Song, J.; Xia, M.; Wang, Y.; Meng, D.; Wang, H.; Li, R. Photocatalytic and electrochemical properties of CeO2 with lamellar structure inherited from cerium oxalate complex. J. Porous Mater. 2017, 24, 1089–1094. [Google Scholar] [CrossRef]
  43. Brittain, H.G.; Sachs, C.J.; Lynch, J.F.; Ogle, K.M.; Perry, D.L. Spectroscopic studies of the thermal decomposition products of hydrated cerous oxalate. Inorg. Chim. Acta 1987, 127, 229–236. [Google Scholar] [CrossRef]
  44. Millo, A.; Raichlin, Y.; Katzir, A. Mid-infrared fiber-optic attenuated total reflection spectroscopy of the solid–liquid phase transition of water. Appl. Spectrosc. 2005, 59, 460–466. [Google Scholar] [CrossRef] [PubMed]
  45. Nakamoto, K. Infrared and Raman Spectra of Inorganic and Coordination Compounds. In Handbook of Vibrational Spectroscopy; John Wiley & Sons, Ltd.: New York, NY, USA, 2006; Available online: https://doi.org/10.1002/0470027320.s4104 (accessed on 17 August 2020).
  46. Li, F.; Koopal, L.; Tan, W. Roles of different types of oxalate surface complexes in dissolution process of ferrihydrite aggregates. Sci. Rep. 2018, 8, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Andreescu, D.; Matijević, E.; Goia, D.V. Formation of uniform colloidal ceria in polyol. Colloids Surf. A Physicochem. Eng. Asp. 2006, 291, 93–100. [Google Scholar] [CrossRef]
  48. Darroudi, M.; Hoseini, S.J.; Oskuee, R.K.; Hosseini, H.A.; Gholami, L.; Gerayli, S. Food-directed synthesis of cerium oxide nanoparticles and their neurotoxicity effects. Ceram. Int. 2014, 40, 7425–7430. [Google Scholar] [CrossRef]
  49. Balakrishnan, G.; Raghavan, C.; Ghosh, C.; Divakar, R.; Mohandas, E.; Song, J.I.; Bae, S.; Kim, T.G. X-ray diffraction, Raman and photoluminescence studies of nanocrystalline cerium oxide thin films. Ceram. Int. 2013, 39, 8327–8333. [Google Scholar] [CrossRef]
  50. Jayakumar, G.; Irudayaraj, A.A.; Raj, A.D. A comprehensive investigation on the properties of nanostructured cerium oxide. Opt. Quantum Electron. 2019, 51, 312. [Google Scholar] [CrossRef]
  51. Khan, M.M.; Khan, W.; Ahamed, M.; Alhazaa, A.N. Microstructural properties and enhanced photocatalytic performance of Zn doped CeO2 nanocrystals. Sci. Rep. 2017, 7, 1–11. [Google Scholar]
  52. Ansari, S.A.; Khan, M.M.; Ansari, M.O.; Kalathil, S.; Lee, J.; Cho, M.H. Band gap engineering of CeO2 nanostructure using an electrochemically active biofilm for visible light applications. Rsc Adv. 2014, 4, 16782–16791. [Google Scholar] [CrossRef]
  53. Choudhury, B.; Chetri, P.; Choudhury, A. Oxygen defects and formation of Ce3+ affecting the photocatalytic performance of CeO2 nanoparticles. RSC Adv. 2014, 4, 4663–4671. [Google Scholar] [CrossRef]
  54. Sharpe, E.; Andreescu, D.; Andreescu, S. Artificial nanoparticle antioxidants. In Oxidative Stress: Diagnostics, Prevention, and Therapy; ACS Symposium Series eBooks; ACS Publications: Washington, DC, USA, 2011; pp. 235–253. [Google Scholar]
  55. Al-Attar, A.M. Antioxidant effect of vitamin E treatment on some heavy metals-induced renal and testicular injuries in male mice. Saudi J. Biol. Sci. 2011, 18, 63–72. [Google Scholar] [CrossRef] [Green Version]
  56. Collin, V.C.; Eymery, F.; Genty, B.; Rey, P.; Havaux, M. Vitamin E is essential for the tolerance of Arabidopsis thaliana to metal-induced oxidative stress. Plant Cell Environ. 2008, 31, 244–257. [Google Scholar] [CrossRef] [PubMed]
  57. Farias, I.A.P.; Santos, C.C.L.D.; Sampaio, F.C. Antimicrobial activity of cerium oxide nanoparticles on opportunistic microorganisms: A systematic review. BioMed Res. Int. 2018, 2018. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Thakur, N.; Manna, P.; Das, J. Synthesis and biomedical applications of nanoceria, a redox active nanoparticle. J. Nanobiotechnology 2019, 17, 84. [Google Scholar] [CrossRef]
  59. Zhang, M.; Zhang, C.; Zhai, X.; Luo, F.; Du, Y.; Yan, C. Antibacterial mechanism and activity of cerium oxide nanoparticles. Sci. China Mater. 2019, 62, 1–13. [Google Scholar] [CrossRef] [Green Version]
  60. Zhang, M.; Yuan, R.; Chai, Y.; Wang, C.; Wu, X. Cerium oxide–graphene as the matrix for cholesterol sensor. Anal. Biochem. 2013, 436, 69–74. [Google Scholar] [CrossRef]
  61. Bellio, P.; Luzi, C.; Mancini, A.; Cracchiolo, S.; Passacantando, M.; Di Pietro, L.; Perilli, M.; Amicosante, G.; Santucci, S.; Celenza, G. Cerium oxide nanoparticles as potential antibiotic adjuvant. Effects of CeO2 nanoparticles on bacterial outer membrane permeability. Biochim. Biophys. Acta (BBA) Biomembr. 2018, 1860, 2428–2435. [Google Scholar] [CrossRef]
  62. Sykes, J.E. Chapter 36—Gram-negative Bacterial Infections. In Canine and Feline Infectious Diseases; Sykes, J.E., Ed.; W.B. Saunders: Saint Louis, MO, USA, 2014; pp. 355–363. [Google Scholar]
  63. Hett, E.C.; Rubin, E.J. Bacterial growth and cell division: A mycobacterial perspective. Microbiol. Mol. Biol. Rev. 2008, 72, 126–156. [Google Scholar] [CrossRef] [Green Version]
Nanomaterials 10 01614 g001 550
Figure 1. (a) Thermal analysis of the cerium oxalate precursor (total theoretical weight loss is 52.49%). (b) XRD pattern recorded at room temperature for CeO2 nanoparticles (nps).
Figure 1. (a) Thermal analysis of the cerium oxalate precursor (total theoretical weight loss is 52.49%). (b) XRD pattern recorded at room temperature for CeO2 nanoparticles (nps).
Nanomaterials 10 01614 g001
Nanomaterials 10 01614 g002 550
Figure 2. TEM and HRTEM images (a,b) and DLS measurement (c) of thermally treated CeO2 nps. The scales are 1 μm (a) and 20 nm (b).
Figure 2. TEM and HRTEM images (a,b) and DLS measurement (c) of thermally treated CeO2 nps. The scales are 1 μm (a) and 20 nm (b).
Nanomaterials 10 01614 g002
Nanomaterials 10 01614 g003 550
Figure 3. (a) FTIR spectra of cerium oxalate–type precursor and CeO2 nps (4000–350 cm−1). (b) Raman spectrum of CeO2 nps.
Figure 3. (a) FTIR spectra of cerium oxalate–type precursor and CeO2 nps (4000–350 cm−1). (b) Raman spectrum of CeO2 nps.
Nanomaterials 10 01614 g003
Nanomaterials 10 01614 g004 550
Figure 4. UV–Vis diffuse absorption spectra of the obtained CeO2 nps and optical band gap determination from the plot of (αhν)2 versus photon energy (αh)—the inset.
Figure 4. UV–Vis diffuse absorption spectra of the obtained CeO2 nps and optical band gap determination from the plot of (αhν)2 versus photon energy (αh)—the inset.
Nanomaterials 10 01614 g004
Nanomaterials 10 01614 g005 550
Figure 5. Antioxidant capacity of CeO2 nps estimated by ABTS•−assays (expressed as μmol trolox /g sample).
Figure 5. Antioxidant capacity of CeO2 nps estimated by ABTS•−assays (expressed as μmol trolox /g sample).
Nanomaterials 10 01614 g005
Nanomaterials 10 01614 g006a 550Nanomaterials 10 01614 g006b 550
Figure 6. LIVE/DEAD® BacLight™ bacterial viability kit control (left) and after 24 h of treatment with 50 µg/mL CeO2 nps (right): Escherichia coli, Salmonella typhimurium, Listeria monocytogenes, Staphylococcus aureus, and Bacillus cereus. Live cells (expressing SYTO® 9) are shown in green, and dead cells (expressing propidium iodide) are shown in red. (Original magnification: × 60).
Figure 6. LIVE/DEAD® BacLight™ bacterial viability kit control (left) and after 24 h of treatment with 50 µg/mL CeO2 nps (right): Escherichia coli, Salmonella typhimurium, Listeria monocytogenes, Staphylococcus aureus, and Bacillus cereus. Live cells (expressing SYTO® 9) are shown in green, and dead cells (expressing propidium iodide) are shown in red. (Original magnification: × 60).
Nanomaterials 10 01614 g006aNanomaterials 10 01614 g006b
Nanomaterials 10 01614 g007 550
Figure 7. Time kill assay of CeO2 nps against the Gram-negative bacteria (E. coli and Salmonella) (a) and Gram-positive bacteria (Listeria, S. aureus, and B. cereus) (b).
Figure 7. Time kill assay of CeO2 nps against the Gram-negative bacteria (E. coli and Salmonella) (a) and Gram-positive bacteria (Listeria, S. aureus, and B. cereus) (b).
Nanomaterials 10 01614 g007
Table
Table 1. Antibacterial activity of CeO2 nps at 50 µg/mL and gentamicin 10 µg/mL, against pathogenic bacteria.
Table 1. Antibacterial activity of CeO2 nps at 50 µg/mL and gentamicin 10 µg/mL, against pathogenic bacteria.
Pathogenic BacteriaCeO2 nps Zone of Inhibition (mm Diameter)Gentamicin Zone of Inhibition (mm Diameter)
G -Escherichia coli9 ± 0.0515 ± 0.43
Salmonella typhimurium12 ± 0.0217 ± 0.02
G +Listeria monocytogenes10 ± 0.0419 ± 0.01
Staphylococcus aureus5 ± 0.0218 ± 0.02
Bacillus cereus7 ± 0.0516 ± 0.01
Table
Table 2. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of CeO2 nps/gentamicin against pathogenic bacteria. Experiments were performed in triplicates and were repeated twice.
Table 2. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of CeO2 nps/gentamicin against pathogenic bacteria. Experiments were performed in triplicates and were repeated twice.
Bacterial StrainsCeO2 nps MIC (mg/mL)Gentamicin MIC (mg/mL)CeO2 nps MBC (mg/mL)
Escherichia coli2.153.02.15
Salmonella typhimurium1.070.381.07
Listeria monocytogenes1.071.21.07
Staphylococcus aureus100.8310
Bacillus cereus4.30.394.3

Share and Cite

MDPI and ACS Style

Pop, O.L.; Mesaros, A.; Vodnar, D.C.; Suharoschi, R.; Tăbăran, F.; Magerușan, L.; Tódor, I.S.; Diaconeasa, Z.; Balint, A.; Ciontea, L.; et al. Cerium Oxide Nanoparticles and Their Efficient Antibacterial Application In Vitro against Gram-Positive and Gram-Negative Pathogens. Nanomaterials 2020, 10, 1614. https://doi.org/10.3390/nano10081614

AMA Style

Pop OL, Mesaros A, Vodnar DC, Suharoschi R, Tăbăran F, Magerușan L, Tódor IS, Diaconeasa Z, Balint A, Ciontea L, et al. Cerium Oxide Nanoparticles and Their Efficient Antibacterial Application In Vitro against Gram-Positive and Gram-Negative Pathogens. Nanomaterials. 2020; 10(8):1614. https://doi.org/10.3390/nano10081614

Chicago/Turabian Style

Pop, Oana L., Amalia Mesaros, Dan C. Vodnar, Ramona Suharoschi, Flaviu Tăbăran, Lidia Magerușan, István Sz. Tódor, Zoriţa Diaconeasa, Adriana Balint, Lelia Ciontea, and et al. 2020. "Cerium Oxide Nanoparticles and Their Efficient Antibacterial Application In Vitro against Gram-Positive and Gram-Negative Pathogens" Nanomaterials 10, no. 8: 1614. https://doi.org/10.3390/nano10081614

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop